J Korean Diabetes.  2024 Jun;25(2):57-61. 10.4093/jkd.2024.25.2.57.

Technological Innovations Transforming Diabetes Care in Practice

• Kang S

• KMID: 2556754
• DOI: http://doi.org/10.4093/jkd.2024.25.2.57

Abstract

Diabetes care has experienced great changes due to technological advancements. Recent notable innovations in diabetes technology include real-time continuous glucose monitors, automated insulin delivery systems, insulin patches, and health management applications based on smartwatches and smartphones. Along with the development of these digital devices, there have been efforts to integrate patient-generated health data, including blood glucose/blood pressure, diet, exercise, and sleep, with hospital electronic health records for direct use in diabetes care. In addition, advancements and cost reductions in omics technologies, including genomics, are expected to enable personalized diagnosis, treatment, and prevention of diabetes through modeling based on vast amounts of related data, from multi-omics to patient-generated health data, using artificial intelligence. This is ultimately expected to advance precision medicine for diabetes in the future.

Keyword

test; Diabetes mellitus; Digital technology; Patient generated health data; Precision medicine; Wearable electronic devices

Reference

1.Park S., Lee H., Cho W., Woo HG., Lim H., Kim S, et al. Efficacy of information and communication technology interventions for the management of diabetes mellitus: an umbrella review and evidence map. Obes Rev. 2024. 25:e13714.

2.Lee EY., Cha SA., Yun JS., Lim SY., Lee JH., Ahn YB, et al. Efficacy of personalized diabetes self-care using an electronic medical record-integrated mobile app in patients with type 2 diabetes: 6-month randomized controlled trial. J Med Internet Res. 2022. 24:e37430.

3.Berget C., Messer LH., Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy. Diabetes Spectr. 2019. 32:194–204.

4.Mackenzie SC., Sainsbury CAR., Wake DJ. Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges. Diabetologia. 2024. 67:223–35.

5.Jendle J., Adolfsson P., Choudhary P., Dovc K., Fleming A., Klonoff DC, et al. A narrative commentary about in-teroperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective. Diabetologia. 2024. 67:236–45.

6.Hodgson W., Kirk A., Lennon M., Paxton G. Exploring the use of Fitbit consumer activity trackers to support active lifestyles in adults with type 2 diabetes: a mixed-methods study. Int J Environ Res Public Health. 2021. 18:11598.

7.Moschonis G., Siopis G., Jung J., Eweka E., Willems R., Kwas-nicka D, et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health. 2023. 5:e125–43.

8.Lee J., Yu J., Yoon KH. Opening the precision diabetes care through digital healthcare. Diabetes Metab J. 2023. 47:307–14.

9.Nolan JJ., Kahkoska AR., Semnani-Azad Z., Hivert MF., Ji L., Mohan V, et al. ADA/EASD precision medicine in diabetes initiative: an international perspective and future vision for precision medicine in diabetes. Diabetes Care. 2022. 45:261–6.